|

Spironolactone Clinical Trials

5 actively recruiting trials across 2 locations

No change since June 2026

Also known as: S, Spironolactone Mylan 25mg

Pipeline

Early 1: 2Phase 2: 1Phase 3: 1Phase 1/2: 1

Top Sponsors

  • University of Virginia2
  • University Hospital, Strasbourg, France1
  • Mayo Clinic1
  • Hospices Civils de Lyon1

Indications

Other2 trials

Blockade of the Renin-angiotensin-aldosterone System in Patients With ARVD
Phase 2
Evaluation of Spironolactone Efficacy in Patient with Rheumatoid Arthritis (RA)
Phase 3

Charlottesville, Virginia2 trials

Does Spironolactone Normalize Sleep-wake Luteinizing Hormone Pulse Frequency in Pubertal Girls With Hyperandrogenism?

Center for Research in Reproduction, University of Virginia

Early 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns

University of Virginia Clinical Research Unit

Early 1

Rochester, Minnesota1 trial

HEART: Pilot Randomized Controlled Trial

Mayo Clinic in Rochester

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.